Aurora improves offerings in australia with new range of premium dried flower products

Nasdaq | tsx: acb canada's leading medical cannabis company and medreleaf australia launch innovative product to offer greater choice for patients edmonton, ab , april 30, 2024 /prnewswire/ - aurora cannabis inc. (nasdaq: acb) (tsx: acb) – the canadian based leading global medical cannabis company, in conjunction with medreleaf australia, is pleased to announce the expansion of its portfolio with the introduction of a new range of premium dried cannabis flower products. now available for doctors to prescribe to patients in australia, the new products developed by aurora and manufactured at its eu-gmp and tga-gmp certified facility, will be distributed by medreleaf australia, a premier distributor of medical cannabis products holding the second position in the australian market.
ACB Ratings Summary
ACB Quant Ranking